Can a surgeon perform lumbar fusion on a patient with mild anemia (hemoglobin 11 g/dL, red blood cell count 3.8 ×10⁶/µL)?

Should Surgery Proceed with Hemoglobin 11 g/dL and RBC 3.8?

Surgery should ideally be delayed for anemia optimization, as a hemoglobin of 11 g/dL represents mild anemia that significantly increases transfusion risk, complications, and impairs functional recovery after lumbar fusion. However, the final decision depends on the urgency of surgery and the patient's sex.

Risk Stratification by Sex

The decision differs based on patient sex due to different anemia thresholds:

For Female Patients (Hb 11 g/dL)

• This patient falls into a moderate-risk category 1
• Female patients with Hb 11.0-12.4 g/dL have:
  • 1.35× likelihood of requiring transfusion
  • 1.52× increased risk of 90-day major complications 1
• Recommendation: Proceed with caution if surgery is urgent, but strongly consider optimization if elective

For Male Patients (Hb 11 g/dL)

• This patient falls into a high-risk category 1
• Male patients with Hb <11.9 g/dL have:
  • 2.95× likelihood of requiring transfusion
  • 2.02× increased risk of 90-day major complications
  • 2.11× increased risk of 2-year infections 1
• Recommendation: Delay surgery for optimization unless emergent

Evidence-Based Rationale

The NATA guidelines explicitly recommend targeting normal hemoglobin ranges before elective orthopaedic surgery 2. The guidelines state that preoperative anemia is associated with increased perioperative morbidity, mortality, and blood transfusion likelihood.

Recent high-quality research demonstrates that even mild anemia (Hb 10-13 g/dL for males, 10-12 g/dL for females) independently predicts:

• Increased transfusion requirements (OR: 5.25-7.48) 3, 4
• Non-home discharge (OR: 1.71-2.00) 4
• Longer hospital stays 4
• Worse functional recovery with higher ODI scores and leg pain at 3 months and 1 year 5

Optimization Protocol (If Surgery Delayed)

Obtain hemoglobin measurement 28 days before surgery 2:

1. Investigate the cause immediately:

   • Check iron studies (ferritin, TIBC, transferrin saturation)
   • Assess for nutritional deficiencies (B12, folate)
   • Evaluate for chronic kidney disease (creatinine, eGFR)
   • Screen for chronic inflammatory conditions 2

2. Treat identified deficiencies:

   • Iron supplementation for iron deficiency (Grade 1C recommendation) 2
   • Correct B12/folate deficiencies
   • Consider erythropoiesis-stimulating agents if nutritional causes ruled out or corrected (Grade 2A) 2

3. Target hemoglobin within normal WHO range:

   • Males: ≥13 g/dL
   • Females: ≥12 g/dL 2

If Surgery Must Proceed

When surgery cannot be delayed, implement these perioperative strategies:

• Prepare for likely transfusion: Have blood products available
• Optimize surgical technique: Minimize blood loss through meticulous hemostasis
• Monitor closely: Frequent hemoglobin checks postoperatively
• Consider cell salvage: Intraoperative blood recovery if available 6
• Counsel patient extensively: Explain increased risks of transfusion (52.2% vs 2.69% for severe vs no anemia), non-home discharge, readmission, and prolonged recovery 4, 5

Critical Pitfalls to Avoid

1. Don't dismiss Hb 11 as "acceptable" - This represents clinically significant anemia for lumbar fusion with measurable impact on outcomes 1, 3, 4

2. Don't use arbitrary transfusion triggers - The ASA guidelines note that Hb 6-10 g/dL requires individualized assessment, but this applies to intraoperative management, not preoperative optimization 6

3. Don't ignore the RBC count of 3.8 - While hemoglobin is the primary concern, low RBC count confirms true anemia rather than hemodilution

4. Don't proceed without investigating the cause - Undiagnosed bleeding disorders, malignancy, or other pathology may be present 2

The evidence strongly supports that anemia is a treatable medical condition, not just an abnormal lab value 2, and optimization improves patient outcomes including reduced transfusions, complications, and better functional recovery 1, 3, 4, 5.